With all the topics we covered on our blog this year, it’s a challenge to pick our favorite post. Throughout 2016 we shared interviews with patients; news about partnerships and initiatives that help support patients and science; stories that illustrate our focus on advancing patient health and access to care; and much more.
From the dozens of blog posts we published this year, we put together a list of some of our favorites that we want to make sure you catch before the year is over. As always, we look forward to bringing you new, valuable posts right here all next year.
In this series, we featured the work AstraZeneca is doing to develop personalized treatments and programs that are uniquely tailored to the individual patient. We also took a deep dive into three therapeutic areas in this series:
One Brave Idea™ is a new initiative, formed through a collaboration of the American Heart Association, Verily (formerly Google Life Sciences) and AstraZeneca, that set out to identify a visionary leader who would lead the research charge to end coronary heart disease and improve the cardiovascular health of people around the world. In October we announced the recipient of the $75 million research award and shared how this individual will take on this challenge.
In November we shared the first in a series on our blog that showcases the ways in which AstraZeneca, through our corporate responsibility investments, supports organizations, programs and policies that advance patient and community health beyond the medicine. We do this by addressing unmet patient needs, driving health and science innovation and supporting the communities where we live and work.
Catch the highlights of AstraZeneca’s 5th Annual Women’s Summit, an employee-driven event that aims to heighten awareness of the challenges women face in their professional lives. This year’s theme, “Succeeding Together: The Power of Diversity,” put a spotlight on how essential diversity of thought is to our business of innovation.
Building upon the success of the 2015 Diabetes Linkup, AstraZeneca gathered type 2 diabetes online influencers together in Gaithersburg to discuss and share strategies for strengthening the voices of these advocates to in turn help patients with this disease.
In 2015, AstraZeneca’s AZ&Me™ Prescription Savings Programs provided more than $617 million in prescription savings to nearly 286,000 patients in the United States. See the impact these programs have on patients and learn if you are eligible for assistance.
Stay tuned for more from the AZ&You AstraZeneca US blog in 2017. If you would like to receive new blog articles in your inbox, go here and click “Sign Up.”